Global Glaucoma Treatment Market Growth (Status and Outlook) 2023-2029

Glaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.

LPI (LP Information)' newest research report, the “Glaucoma Treatment Industry Forecast” looks at past sales and reviews total world Glaucoma Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Glaucoma Treatment sales for 2023 through 2029. With Glaucoma Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glaucoma Treatment industry.

This Insight Report provides a comprehensive analysis of the global Glaucoma Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glaucoma Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glaucoma Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glaucoma Treatment and breaks down the forecast by product, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glaucoma Treatment.

The global Glaucoma Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

In the Hong Kong market, the main Glaucoma Treatment players include Novartis, Allergan, Pfizer, Akorn, etc. The top four Glaucoma Treatment players account for approximately 60% of the total global market. In terms of Product, Prostaglandin Analogs (PGAs) is the largest segment with a share of 52%. And in terms of Applications, the largest segment is Clinic, followed by Pharmacy.

This report presents a comprehensive overview, market shares, and growth opportunities of Glaucoma Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by product
    Prostaglandin Analogs (PGAs)
    Beta Blocker
    Alpha Agonist
    Others

Segmentation by application
    Clinic
    Pharmacy
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Novartis
    Allergan
    Pfizer
    Akorn
    Teva
    Bausch & Lomb
    Otsuka Pharmaceutical
    Santen
    Lunan Pharma
    Zizhu Pharma

List of Tables
    Table 1. Glaucoma Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
    Table 2. Major Players of Prostaglandin Analogs (PGAs)
    Table 3. Major Players of Beta Blocker
    Table 4. Major Players of Alpha Agonist
    Table 5. Major Players of Others
    Table 6. Glaucoma Treatment Market Size CAGR by Product (2018 VS 2022 VS 2029) & ($ Millions)
    Table 7. Global Glaucoma Treatment Market Size by Product (2018-2023) & ($ Millions)
    Table 8. Global Glaucoma Treatment Market Size Market Share by Product (2018-2023)
    Table 9. Glaucoma Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
    Table 10. Global Glaucoma Treatment Market Size by Application (2018-2023) & ($ Millions)
    Table 11. Global Glaucoma Treatment Market Size Market Share by Application (2018-2023)
    Table 12. Global Glaucoma Treatment Revenue by Players (2018-2023) & ($ Millions)
    Table 13. Global Glaucoma Treatment Revenue Market Share by Player (2018-2023)
    Table 14. Glaucoma Treatment Key Players Head office and Products Offered
    Table 15. Glaucoma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
    Table 16. New Products and Potential Entrants
    Table 17. Mergers & Acquisitions, Expansion
    Table 18. Global Glaucoma Treatment Market Size by Regions 2018-2023 & ($ Millions)
    Table 19. Global Glaucoma Treatment Market Size Market Share by Regions (2018-2023)
    Table 20. Global Glaucoma Treatment Revenue by Country/Region (2018-2023) & ($ millions)
    Table 21. Global Glaucoma Treatment Revenue Market Share by Country/Region (2018-2023)
    Table 22. Americas Glaucoma Treatment Market Size by Country (2018-2023) & ($ Millions)
    Table 23. Americas Glaucoma Treatment Market Size Market Share by Country (2018-2023)
    Table 24. Americas Glaucoma Treatment Market Size by Product (2018-2023) & ($ Millions)
    Table 25. Americas Glaucoma Treatment Market Size Market Share by Product (2018-2023)
    Table 26. Americas Glaucoma Treatment Market Size by Application (2018-2023) & ($ Millions)
    Table 27. Americas Glaucoma Treatment Market Size Market Share by Application (2018-2023)
    Table 28. APAC Glaucoma Treatment Market Size by Region (2018-2023) & ($ Millions)
    Table 29. APAC Glaucoma Treatment Market Size Market Share by Region (2018-2023)
    Table 30. APAC Glaucoma Treatment Market Size by Product (2018-2023) & ($ Millions)
    Table 31. APAC Glaucoma Treatment Market Size Market Share by Product (2018-2023)
    Table 32. APAC Glaucoma Treatment Market Size by Application (2018-2023) & ($ Millions)
    Table 33. APAC Glaucoma Treatment Market Size Market Share by Application (2018-2023)
    Table 34. Europe Glaucoma Treatment Market Size by Country (2018-2023) & ($ Millions)
    Table 35. Europe Glaucoma Treatment Market Size Market Share by Country (2018-2023)
    Table 36. Europe Glaucoma Treatment Market Size by Product (2018-2023) & ($ Millions)
    Table 37. Europe Glaucoma Treatment Market Size Market Share by Product (2018-2023)
    Table 38. Europe Glaucoma Treatment Market Size by Application (2018-2023) & ($ Millions)
    Table 39. Europe Glaucoma Treatment Market Size Market Share by Application (2018-2023)
    Table 40. Middle East & Africa Glaucoma Treatment Market Size by Region (2018-2023) & ($ Millions)
    Table 41. Middle East & Africa Glaucoma Treatment Market Size Market Share by Region (2018-2023)
    Table 42. Middle East & Africa Glaucoma Treatment Market Size by Product (2018-2023) & ($ Millions)
    Table 43. Middle East & Africa Glaucoma Treatment Market Size Market Share by Product (2018-2023)
    Table 44. Middle East & Africa Glaucoma Treatment Market Size by Application (2018-2023) & ($ Millions)
    Table 45. Middle East & Africa Glaucoma Treatment Market Size Market Share by Application (2018-2023)
    Table 46. Key Market Drivers & Growth Opportunities of Glaucoma Treatment
    Table 47. Key Market Challenges & Risks of Glaucoma Treatment
    Table 48. Key Industry Trends of Glaucoma Treatment
    Table 49. Global Glaucoma Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
    Table 50. Global Glaucoma Treatment Market Size Market Share Forecast by Regions (2024-2029)
    Table 51. Global Glaucoma Treatment Market Size Forecast by Product (2024-2029) & ($ Millions)
    Table 52. Global Glaucoma Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
    Table 53. Novartis Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 54. Novartis Glaucoma Treatment Product Offered
    Table 55. Novartis Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 56. Novartis Main Business
    Table 57. Novartis Latest Developments
    Table 58. Allergan Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 59. Allergan Glaucoma Treatment Product Offered
    Table 60. Allergan Main Business
    Table 61. Allergan Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 62. Allergan Latest Developments
    Table 63. Pfizer Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 64. Pfizer Glaucoma Treatment Product Offered
    Table 65. Pfizer Main Business
    Table 66. Pfizer Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 67. Pfizer Latest Developments
    Table 68. Akorn Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 69. Akorn Glaucoma Treatment Product Offered
    Table 70. Akorn Main Business
    Table 71. Akorn Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 72. Akorn Latest Developments
    Table 73. Teva Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 74. Teva Glaucoma Treatment Product Offered
    Table 75. Teva Main Business
    Table 76. Teva Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 77. Teva Latest Developments
    Table 78. Bausch & Lomb Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 79. Bausch & Lomb Glaucoma Treatment Product Offered
    Table 80. Bausch & Lomb Main Business
    Table 81. Bausch & Lomb Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 82. Bausch & Lomb Latest Developments
    Table 83. Otsuka Pharmaceutical Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 84. Otsuka Pharmaceutical Glaucoma Treatment Product Offered
    Table 85. Otsuka Pharmaceutical Main Business
    Table 86. Otsuka Pharmaceutical Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 87. Otsuka Pharmaceutical Latest Developments
    Table 88. Santen Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 89. Santen Glaucoma Treatment Product Offered
    Table 90. Santen Main Business
    Table 91. Santen Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 92. Santen Latest Developments
    Table 93. Lunan Pharma Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 94. Lunan Pharma Glaucoma Treatment Product Offered
    Table 95. Lunan Pharma Main Business
    Table 96. Lunan Pharma Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 97. Lunan Pharma Latest Developments
    Table 98. Zizhu Pharma Details, Company Type, Glaucoma Treatment Area Served and Its Competitors
    Table 99. Zizhu Pharma Glaucoma Treatment Product Offered
    Table 100. Zizhu Pharma Main Business
    Table 101. Zizhu Pharma Glaucoma Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
    Table 102. Zizhu Pharma Latest Developments
List of Figures
    Figure 1. Glaucoma Treatment Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Glaucoma Treatment Market Size Growth Rate 2018-2029 ($ Millions)
    Figure 6. Glaucoma Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Figure 7. Glaucoma Treatment Sales Market Share by Country/Region (2022)
    Figure 8. Glaucoma Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
    Figure 9. Global Glaucoma Treatment Market Size Market Share by Product in 2022
    Figure 10. Glaucoma Treatment in Clinic
    Figure 11. Global Glaucoma Treatment Market: Clinic (2018-2023) & ($ Millions)
    Figure 12. Glaucoma Treatment in Pharmacy
    Figure 13. Global Glaucoma Treatment Market: Pharmacy (2018-2023) & ($ Millions)
    Figure 14. Glaucoma Treatment in Other
    Figure 15. Global Glaucoma Treatment Market: Other (2018-2023) & ($ Millions)
    Figure 16. Global Glaucoma Treatment Market Size Market Share by Application in 2022
    Figure 17. Global Glaucoma Treatment Revenue Market Share by Player in 2022
    Figure 18. Global Glaucoma Treatment Market Size Market Share by Regions (2018-2023)
    Figure 19. Americas Glaucoma Treatment Market Size 2018-2023 ($ Millions)
    Figure 20. APAC Glaucoma Treatment Market Size 2018-2023 ($ Millions)
    Figure 21. Europe Glaucoma Treatment Market Size 2018-2023 ($ Millions)
    Figure 22. Middle East & Africa Glaucoma Treatment Market Size 2018-2023 ($ Millions)
    Figure 23. Americas Glaucoma Treatment Value Market Share by Country in 2022
    Figure 24. United States Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 25. Canada Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 26. Mexico Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 27. Brazil Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 28. APAC Glaucoma Treatment Market Size Market Share by Region in 2022
    Figure 29. APAC Glaucoma Treatment Market Size Market Share by Product in 2022
    Figure 30. APAC Glaucoma Treatment Market Size Market Share by Application in 2022
    Figure 31. China Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 32. Japan Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 33. Korea Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 34. Southeast Asia Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 35. India Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 36. Australia Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 37. Europe Glaucoma Treatment Market Size Market Share by Country in 2022
    Figure 38. Europe Glaucoma Treatment Market Size Market Share by Product (2018-2023)
    Figure 39. Europe Glaucoma Treatment Market Size Market Share by Application (2018-2023)
    Figure 40. Germany Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 41. France Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 42. UK Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 43. Italy Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 44. Russia Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 45. Middle East & Africa Glaucoma Treatment Market Size Market Share by Region (2018-2023)
    Figure 46. Middle East & Africa Glaucoma Treatment Market Size Market Share by Product (2018-2023)
    Figure 47. Middle East & Africa Glaucoma Treatment Market Size Market Share by Application (2018-2023)
    Figure 48. Egypt Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 49. South Africa Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 50. Israel Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 51. Turkey Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 52. GCC Country Glaucoma Treatment Market Size Growth 2018-2023 ($ Millions)
    Figure 53. Americas Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 54. APAC Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 55. Europe Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 56. Middle East & Africa Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 57. United States Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 58. Canada Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 59. Mexico Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 60. Brazil Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 61. China Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 62. Japan Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 63. Korea Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 64. Southeast Asia Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 65. India Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 66. Australia Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 67. Germany Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 68. France Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 69. UK Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 70. Italy Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 71. Russia Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 72. Spain Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 73. Egypt Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 74. South Africa Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 75. Israel Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 76. Turkey Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 77. GCC Countries Glaucoma Treatment Market Size 2024-2029 ($ Millions)
    Figure 78. Global Glaucoma Treatment Market Size Market Share Forecast by Product (2024-2029)
    Figure 79. Global Glaucoma Treatment Market Size Market Share Forecast by Application (2024-2029)

Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape